Albany Molecular (AMRI) Posts Q2 adj.-EPS of $0.06, Tops Views; Guides Q3 and FY10
Tweet Send to a Friend
Albany Molecular Research, Inc. (Nasdaq: AMRI) reports Q2 adjusted EPS of $0.06, 10 cents better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
